Clinical Trial

AD-SVF Therapy for Refractory Endometrial Infertility

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to initially explore the efficacy of adipose-derived stromal vascular fraction (AD-SVF) therapy in the treatment of refractory endometrial infertility.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-13.
Trial Details
NCT Number NCT07230600
Lead Sponsor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions Endometrium; Atrophy, Intrauterine Synechiae
Enrollment 10 participants
Start Date 2025-11
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-18